We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Legacy Housing
LEGH
$634M
| $226K | ﹤0.01% |
+18,146
| New | +$220K |
|
1227
Invesco China Technology ETF
CQQQ
$3.07B
| $224K | ﹤0.01% |
+4,934
| New | +$232K |
|
1228
Aegon
AEG
$13.5B
| $223K | ﹤0.01% |
50,872
-160,598
| -76% | -$684K |
|
1229
Resources Connection
RGP
$134M
| $220K | ﹤0.01% |
13,759
-96,542
| -88% | -$1.54M |
|
|
1230
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.4B
| $219K | ﹤0.01% |
+5,500
| New | +$233K |
|
1231
Movado Group
MOV
$817M
| $218K | ﹤0.01% |
8,072
-26,890
| -77% | -$845K |
|
1232
Vitamin Cottage Natural Grocers
NGVC
$720M
| $217K | ﹤0.01% |
+21,582
| New | +$247K |
|
1233
Protagonist Therapeutics
PTGX
$8.79B
| $216K | ﹤0.01% |
+17,799
| New | +$197K |
|
1234
Equinor
EQNR
$92.9B
| $213K | ﹤0.01% |
+10,777
| New | +$227K |
|
1235
JPMorgan Chase
JPM
$939B
| $212K | ﹤0.01% |
1,893
-66,565
| -97% | -$7.34M |
|
1236
Vistra
VST
$52.6B
| $212K | ﹤0.01% |
+9,369
| New | +$235K |
|
1237
Builders FirstSource
BLDR
$7.83B
| $209K | ﹤0.01% |
12,437
-242,141
| -95% | -$3.62M |
|
1238
Cato Corp
CATO
$64.1M
| $209K | ﹤0.01% |
+16,938
| New | +$231K |
|
|
STEL
1239
DELISTED
Stellar Bancorp
STEL
| $209K | ﹤0.01% |
+7,437
| New | +$220K |
|
1240
TIM SA
TIMB
$10.1B
| $209K | ﹤0.01% |
13,986
-576,866
| -98% | -$8.37M |
|
1241
Coherus Oncology
CHRS
$227M
| $207K | ﹤0.01% |
+9,339
| New | +$162K |
|
|
EEX
1242
DELISTED
Emerald Holding
EEX
| $204K | ﹤0.01% |
18,253
-84,033
| -82% | -$1.05M |
|
1243
Spero Therapeutics
SPRO
$69.5M
| $204K | ﹤0.01% |
17,699
+14,625
| +476% | +$176K |
|
1244
Semtech
SMTC
$11.1B
| $203K | ﹤0.01% |
+4,217
| New | +$205K |
|
|
CBL
1245
DELISTED
CBL& Associates Properties, Inc.
CBL
| $197K | ﹤0.01% |
189,097
-509,492
| -73% | -$589K |
|
1246
Horizon Bancorp
HBNC
$1.04B
| $196K | ﹤0.01% |
11,974
+10,374
| +648% | +$168K |
|
|
KDMN
1247
DELISTED
Kadmon Holdings, Inc.
KDMN
| $196K | ﹤0.01% |
94,683
-52,679
| -36% | -$117K |
|
1248
American Vanguard Corp
AVD
$75.5M
| $194K | ﹤0.01% |
+12,575
| New | +$192K |
|
|
MEET
1249
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $184K | ﹤0.01% |
+52,876
| New | +$235K |
|
1250
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.5B
| $183K | ﹤0.01% |
2,075
-17,825
| -90% | -$2.06M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.